Surgical Treatment of Primary Tracheobronchial Tumors: 16-Year Experience in a Single Center

Yujian Liu,Kaifu Zheng,Qiang Lu,Jian Wang,Yunfeng Ni,Xiaolong Yan,Lei Wang,Xiyang Tang,Jing Huang,Xiaofei Li,Jinbo Zhao
DOI: https://doi.org/10.21037/jtd-21-1791
2022-01-01
Journal of Thoracic Disease
Abstract:Background: Primary tracheobronchial tumor (TBT) is a rare disease, and the prognostic factors of surgical treatment have not been well identified. Methods: Patients with primary TBT and accepted surgical treatment between January 2004 and January 2020 at our institution were retrospectively analyzed. The univariate analysis and multivariate analysis were conducted on the malignant cases. The overall survival (OS) was analyzed using Kaplan-Meier method, and potential prognostic factors were analyzed using Cox regression analysis. Results: A total of 69 patients (29 males and 40 females) were included. The median follow-up duration was 75.7 months (1.2-177.4 months). The most common histology was adenoid cystic carcinoma (ACC) (37.7%) followed by squamous cell carcinoma (SCC) (23.2%). For patients with malignant tumors, the estimated 5-year OS of the overall population was 77.2% and the estimated 5-year OS of SCC patients was 73.8% especially. The univariate Cox regression analysis identified that age and tumor size had significant effects on OS. The multivariate analysis showed that age (<= 50 years or 50 years) was independent prognostic factor for OS (P<0.05). Conclusions: Age is independent factor affecting the OS of primary TBT treated by surgery. And patients of TBT with younger age should be much more referred for surgery.
What problem does this paper attempt to address?